Skip to content
Hindi News, हिंदी समाचार, Samachar, Breaking News, Latest Khabar – Pratirodh

Hindi News, हिंदी समाचार, Samachar, Breaking News, Latest Khabar – Pratirodh

Primary Menu Hindi News, हिंदी समाचार, Samachar, Breaking News, Latest Khabar – Pratirodh

Hindi News, हिंदी समाचार, Samachar, Breaking News, Latest Khabar – Pratirodh

  • Home
  • Newswires
  • Politics & Society
  • The New Feudals
  • World View
  • Arts And Aesthetics
  • For The Record
  • About Us
  • Featured

India’s Coronavirus Infections Rise To 7.4 Million

Oct 16, 2020 | Pratirodh Bureau

Passengers wearing protective face masks stand in a queue on the platform of a railway station to get tested for the coronavirus disease in New Delhi on October 5, 2020

India’s tally of coronavirus infections stood at 7.37 million on Friday, having risen by 63,371 in the last 24 hours, Health Ministry data showed.

Deaths from COVID-19 infections rose by 895 to 112,161, the Ministry said.

India crossed the 7-million mark on Sunday, adding a million cases in just 13 days. It has the world’s second-highest tally after the United States, where the figure is nearing 8 million.

Meanwhile, a Chinese city is offering Sinovac Biotech’s experimental COVID-19 vaccine to essential workers and other high-risk groups, as part of a national programme, for about $60.

The eastern city of Jiaxin’s center for disease control and prevention (CDC) said in a statement on WeChat that two doses of the vaccine candidate, called CoronaVac, will cost 200 yuan ($29.75) per dose and that vaccinations for key groups, including medical professionals, have begun.

Chinese authorities have to date not released pricing details for potential COVID-19 vaccines. Hundreds of thousands of people have been given experimental vaccines in late-stage trials as part of an emergency inoculation programme launched in July.

It was not clear if Jiaxin city’s pricing includes subsidies. The city’s CDC declined to comment.

Sinovac did not immediately respond to a request for comment. Its vaccine is in late stage trials in Brazil, Indonesia and Turkey, and the company has said that an interim analysis of Phase 3 trial data could come as early as November.

Bio Farma, a state-owned firm in Indonesia which has reached a deal for at least 40 million doses from Sinovac, said this week the vaccine will cost around 200,000 rupiah ($13.60) per dose when it becomes available in the southeast Asian country.

China has said that while reasonable profits for companies are permitted, COVID-19 vaccines should be priced close to cost.

 

Tags: CoronaVac, coronavirus infections, COVID-19, experimental COVID-19 vaccine, Health Ministry, Pratirodh

Continue Reading

Previous Delhi Residents Worry About Toxic Mix Of Covid-19, Pollution
Next Kashmir: Major Parties Unite To Fight For Return Of Autonomy

More Stories

  • Featured

Black Days Ahead If Coal City Doesn’t Change

1 day ago Pratirodh Bureau
  • Featured

US Firm Alleges ‘Brazen’ Fraud By Adani, Who Calls It Malicious

2 days ago Pratirodh Bureau
  • Featured

Why Ukraine War Today Is So Different From A Year Ago

2 days ago Pratirodh Bureau

Recent Posts

  • Black Days Ahead If Coal City Doesn’t Change
  • US Firm Alleges ‘Brazen’ Fraud By Adani, Who Calls It Malicious
  • Why Ukraine War Today Is So Different From A Year Ago
  • No Screening Of BBC Docu At JNU As Power, Internet Cut
  • Shielding The Hijol From Climate Impacts
  • Bilkis Bano’s Plea Against Convicts’ Remission Could Not Be Heard In SC
  • NDRF To Station Permanent Teams In Hills For Rescue Operations
  • Thousands Of Indian IT Professionals Jobless In The US
  • How Solar-Powered Refrigerators Slow Down Climate Change
  • Compensation For Crop Loss: Landless, Tenant Farmers Miss Out
  • Peru Closes Machu Picchu As Anti-Government Protests Grow
  • There Was No Need To Scrap Article 370: Dulat
  • RSS Ideology And Netaji’s Ideals Poles Apart: Anita Bose-Pfaff
  • UN Sorry For Photo Of Its Personnel In Front Of Taliban Flag
  • Govt Has Reduced Parliament To Notice Board, Rubber Stamp: Tharoor
  • Decline In China’s Population Will Have Global Implications
  • Documentary On Modi ‘Rigorously Researched’, Says BBC
  • Delhi To Women: Enter At Your Own Risk
  • Opinion: India’s Climate Plan Can’t Work Sans Protecting Forests
  • Elon Musk’s Twitter Is Ripe For An Avalanche Of Misinformation

Search

Main Links

  • Home
  • Newswires
  • Politics & Society
  • The New Feudals
  • World View
  • Arts And Aesthetics
  • For The Record
  • About Us

Related Stroy

  • Featured

Black Days Ahead If Coal City Doesn’t Change

1 day ago Pratirodh Bureau
  • Featured

US Firm Alleges ‘Brazen’ Fraud By Adani, Who Calls It Malicious

2 days ago Pratirodh Bureau
  • Featured

Why Ukraine War Today Is So Different From A Year Ago

2 days ago Pratirodh Bureau
  • Featured

No Screening Of BBC Docu At JNU As Power, Internet Cut

2 days ago Pratirodh Bureau
  • Featured

Shielding The Hijol From Climate Impacts

2 days ago Shalini

Recent Posts

  • Black Days Ahead If Coal City Doesn’t Change
  • US Firm Alleges ‘Brazen’ Fraud By Adani, Who Calls It Malicious
  • Why Ukraine War Today Is So Different From A Year Ago
  • No Screening Of BBC Docu At JNU As Power, Internet Cut
  • Shielding The Hijol From Climate Impacts
Copyright © All rights reserved. | CoverNews by AF themes.